Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × venetoclax × Clear all

NCT04543916 2021-03-03

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

Phase 1/2 Withdrawn

Small Cell Lung Carcinoma